Pharmaceutical

DF-4101 by AbbVie for Non-Small Cell Lung Cancer: Likel...

Apr 21, 2024

DF-4101 is under clinical development by AbbVie and currently in Phase I for Non...

PRO-1107 by ProfoundBio Suzhou for Gastric Cancer: Like...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Solid Tumor: Likelih...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Bladder Cancer: Like...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Non-Small Cell Lung ...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Endometrial Cancer: ...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Transitional Cell Ca...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

PRO-1107 by ProfoundBio Suzhou for Fallopian Tube Cance...

Apr 21, 2024

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Ph...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for...

Apr 19, 2024

SGN-1 is under clinical development by Guangzhou Huajin Pharmaceutical Technolog...

Recommended Posts

STAT+: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

STAT+: Illumina says it will divest Grail, startin...

Dec 17, 2023

Is it time to worry about Moderna?

Is it time to worry about Moderna?

Dec 15, 2023

Blood testing identifies biomarkers of suicidal thoughts

Blood testing identifies biomarkers of suicidal th...

Dec 15, 2023

Monoblock Mastery: Capmatic's Innovative Approach to Integrated Packaging Systems

Monoblock Mastery: Capmatic's Innovative Approach ...

Aug 29, 2023

Follow Us

Twitter
Linkedin